Lupin unveils Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in US
The product is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.
Mumbai: Pharma major, Lupin Limited, today announced the launch of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, having received an approval from the United States Food and Drug Administration (USFDA).
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic equivalent of Suprep Bowel Prep Kit Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, of Braintree Laboratories Inc.
Read also: Lupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 crore
The product is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep Bowel Prep Kit) had estimated annual sales of USD 202 million in the U.S. (IQVIA MAT July 2022).
Read also: Lupin, DKSH ink pact to commercialize 5 of Alvotech proposed biosimilars in Philippines
